Reported 3 days ago
Bristol-Myers Squibb Company (NYSE:BMY), an American pharmaceutical giant, is highlighted as one of the 11 best affordable dividend stocks to buy now. The company has shown significant growth, particularly with its cancer cell therapy Breyanzi and the newly approved schizophrenia treatment Cobenfy. With a dividend increase track record spanning 16 years and a current yield of 5.39%, BMY is positioned for continued growth, although some investors may find higher potential in certain AI stocks.
Source: YAHOO